Abstract | BACKGROUND:
Glioma is the most aggressive and lethal tumor of the central nervous system. Due to the cellular heterogeneity, the invasiveness, and blood-brain barrier (BBB), current therapeutic approaches, such as chemotherapy and radiotherapy, are poorly to obtain great antitumor efficacy. However, peptides, a novel type of therapeutic agent, displayed excellent ability in the tumor, which becomes a new molecule for glioma treatment. METHODS: We review the current knowledge on peptides for the treatment of glioma through a PubMed-based literature search. RESULTS: In the treatment of glioma, peptides can be used as (i) decoration on the surface of the delivery system, facilitating the distribution and accumulation of the anti- tumor drug in target site; (ii) anti- tumor active molecules, inhibiting the growth of glioma and reducing solid tumor volume; (iii) immune-stimulating factor, and it activating immune cells in the tumor microenvironment or recruiting immune cells to the tumor for breaking out the immunosuppression by glioma cells. CONCLUSION: The application of peptides has revolutionized the treatment of glioma, which based on targeting, penetrating, anti- tumor activities and immunostimulatory. Moreover, better outcomes have been discovered in combining different kinds of peptides rather than a single one. Until now, more and more preclinical studies have been developed with multifarious peptides, which shows promising results in vitro or vivo with the model of glioma.
|
Authors | Li Li, Jianhong Chen, Yue Ming, Bin Li, Ruoqiu Fu, Dongyu Duan, Ziwei Li, Rui Ni, Xianfeng Wang, Yueling Zhou, Lin Zhang |
Journal | Current pharmaceutical biotechnology
(Curr Pharm Biotechnol)
Vol. 23
Issue 5
Pg. 620-633
( 2022)
ISSN: 1873-4316 [Electronic] Netherlands |
PMID | 34182908
(Publication Type: Journal Article, Review)
|
Copyright | Copyright© Bentham Science Publishers; For any queries, please email at [email protected]. |
Chemical References |
|
Topics |
- Brain Neoplasms
(drug therapy)
- Cell Line, Tumor
- Drug Delivery Systems
- Glioma
(drug therapy)
- Humans
- Peptides
- Tumor Microenvironment
|